Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8931 |
High Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8864 |
High Similarity |
NPD3027 |
Phase 3 |
0.8855 |
High Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8806 |
High Similarity |
NPD1613 |
Approved |
0.8806 |
High Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8309 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.812 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.8116 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.811 |
Intermediate Similarity |
NPD228 |
Approved |
0.8105 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.8102 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.8065 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8029 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.8013 |
Intermediate Similarity |
NPD37 |
Approved |
0.8 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7955 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7911 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7895 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7868 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7868 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7857 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7857 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7857 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7846 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7794 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.775 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7737 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7737 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7727 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7727 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7727 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7718 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7702 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7698 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7687 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7687 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7622 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7616 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7609 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7606 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7547 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7538 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7538 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7518 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7516 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7516 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7516 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7468 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7464 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7453 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7432 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.7432 |
Intermediate Similarity |
NPD3540 |
Phase 1 |
0.7405 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7397 |
Intermediate Similarity |
NPD4097 |
Suspended |
0.7365 |
Intermediate Similarity |
NPD3539 |
Phase 1 |
0.7358 |
Intermediate Similarity |
NPD4055 |
Discovery |
0.7351 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7338 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7323 |
Intermediate Similarity |
NPD1242 |
Phase 1 |
0.7321 |
Intermediate Similarity |
NPD8054 |
Approved |
0.7321 |
Intermediate Similarity |
NPD8053 |
Approved |
0.7319 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7305 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7297 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7285 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7279 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7273 |
Intermediate Similarity |
NPD4750 |
Phase 3 |
0.7267 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7266 |
Intermediate Similarity |
NPD846 |
Approved |
0.7266 |
Intermediate Similarity |
NPD940 |
Approved |
0.726 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7254 |
Intermediate Similarity |
NPD3094 |
Phase 2 |
0.7252 |
Intermediate Similarity |
NPD2342 |
Discontinued |
0.7248 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7248 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7246 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7246 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7233 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7229 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7222 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7219 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7214 |
Intermediate Similarity |
NPD1611 |
Approved |
0.7212 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7211 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7211 |
Intermediate Similarity |
NPD3657 |
Discovery |
0.7208 |
Intermediate Similarity |
NPD4160 |
Clinical (unspecified phase) |
0.7208 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7206 |
Intermediate Similarity |
NPD709 |
Approved |
0.7203 |
Intermediate Similarity |
NPD4624 |
Approved |
0.7197 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.719 |
Intermediate Similarity |
NPD7124 |
Phase 2 |
0.7183 |
Intermediate Similarity |
NPD6696 |
Suspended |
0.7183 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7169 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7161 |
Intermediate Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD943 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7126 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7123 |
Intermediate Similarity |
NPD5109 |
Approved |
0.7123 |
Intermediate Similarity |
NPD5110 |
Phase 2 |
0.7123 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7123 |
Intermediate Similarity |
NPD5111 |
Phase 2 |
0.7115 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7113 |
Intermediate Similarity |
NPD1669 |
Approved |
0.7111 |
Intermediate Similarity |
NPD7635 |
Approved |
0.7105 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7101 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7097 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7095 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7093 |
Intermediate Similarity |
NPD7906 |
Approved |
0.7092 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7092 |
Intermediate Similarity |
NPD3092 |
Approved |
0.7092 |
Intermediate Similarity |
NPD1281 |
Approved |
0.7089 |
Intermediate Similarity |
NPD4675 |
Approved |
0.7089 |
Intermediate Similarity |
NPD4678 |
Approved |
0.7086 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7086 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7086 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7086 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7086 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.708 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7076 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7073 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7067 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7059 |
Intermediate Similarity |
NPD4577 |
Approved |
0.7059 |
Intermediate Similarity |
NPD3892 |
Phase 2 |
0.7059 |
Intermediate Similarity |
NPD4578 |
Approved |
0.7059 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7055 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7055 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7052 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7044 |
Intermediate Similarity |
NPD5090 |
Approved |
0.7044 |
Intermediate Similarity |
NPD5089 |
Approved |
0.7039 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7035 |
Intermediate Similarity |
NPD4663 |
Approved |
0.7032 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7032 |
Intermediate Similarity |
NPD7041 |
Phase 2 |
0.7032 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7032 |
Intermediate Similarity |
NPD7040 |
Clinical (unspecified phase) |
0.7027 |
Intermediate Similarity |
NPD2238 |
Phase 2 |
0.702 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7013 |
Intermediate Similarity |
NPD5241 |
Discontinued |
0.7013 |
Intermediate Similarity |
NPD2219 |
Phase 1 |
0.7013 |
Intermediate Similarity |
NPD2677 |
Approved |
0.7 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD5691 |
Approved |
0.7 |
Intermediate Similarity |
NPD6111 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7 |
Intermediate Similarity |
NPD4538 |
Approved |
0.6993 |
Remote Similarity |
NPD1652 |
Phase 2 |
0.6993 |
Remote Similarity |
NPD5327 |
Phase 3 |
0.6993 |
Remote Similarity |
NPD3060 |
Approved |
0.6992 |
Remote Similarity |
NPD290 |
Approved |
0.6988 |
Remote Similarity |
NPD27 |
Approved |
0.6988 |
Remote Similarity |
NPD2489 |
Approved |
0.6987 |
Remote Similarity |
NPD2532 |
Approved |
0.6987 |
Remote Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.6987 |
Remote Similarity |
NPD2533 |
Approved |
0.6987 |
Remote Similarity |
NPD2534 |
Approved |
0.6982 |
Remote Similarity |
NPD6797 |
Phase 2 |
0.6982 |
Remote Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.6975 |
Remote Similarity |
NPD7768 |
Phase 2 |
0.697 |
Remote Similarity |
NPD3787 |
Discontinued |
0.697 |
Remote Similarity |
NPD3051 |
Approved |
0.6966 |
Remote Similarity |
NPD6584 |
Phase 3 |
0.6959 |
Remote Similarity |
NPD2674 |
Phase 3 |
0.6959 |
Remote Similarity |
NPD7311 |
Approved |
0.6959 |
Remote Similarity |
NPD7312 |
Approved |
0.6959 |
Remote Similarity |
NPD7313 |
Approved |
0.6959 |
Remote Similarity |
NPD7310 |
Approved |
0.6957 |
Remote Similarity |
NPD7157 |
Approved |
0.6954 |
Remote Similarity |
NPD3748 |
Approved |
0.6954 |
Remote Similarity |
NPD651 |
Clinical (unspecified phase) |
0.6941 |
Remote Similarity |
NPD6559 |
Discontinued |
0.6941 |
Remote Similarity |
NPD7251 |
Discontinued |
0.694 |
Remote Similarity |
NPD2684 |
Approved |
0.6934 |
Remote Similarity |
NPD1398 |
Phase 1 |
0.6933 |
Remote Similarity |
NPD7075 |
Discontinued |
0.6929 |
Remote Similarity |
NPD9296 |
Approved |
0.6929 |
Remote Similarity |
NPD3091 |
Approved |
0.6928 |
Remote Similarity |
NPD2969 |
Approved |
0.6928 |
Remote Similarity |
NPD2970 |
Approved |
0.6927 |
Remote Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD2233 |
Approved |
0.6923 |
Remote Similarity |
NPD2232 |
Approved |
0.6923 |
Remote Similarity |
NPD7390 |
Discontinued |
0.6923 |
Remote Similarity |
NPD2230 |
Approved |
0.6919 |
Remote Similarity |
NPD7309 |
Approved |
0.6918 |
Remote Similarity |
NPD7261 |
Clinical (unspecified phase) |
0.6918
|
Remote Similarity |
NPD9494 |
Approved |